Hezbollah Leader Issues Threat To Israel
Sheik Hassan Nasrallah vowed revenge against Israel, which Hezbollah blames for the killing of a commander....
Read Full Article
Music Review | St. Louis Symphony Orchestra: Demystifying Messiaen, With A Little Help From The Birds
David Robertson and the St. Louis Symphony Orchestra gave an engaging, informative and unabashedly quirky demonstration of how to demystify a daunting contemporary work for the public....
Read Full Article
Alliance Data Says Blackstone Deal Is In Trouble
The credit card services provider said it has received notice from Blackstone that the private equity firm does not expect to complete the deal....
Read Full Article
Hurled Into Dirty River, Logo Floats Gently Away
?Missing: Esquire Logo,? begins a cryptic item posted to Esquire.com on July 12. ?Several days ago, in a burst of enthusiasm during a photo shoot, Benicio del Toro tossed our logo into the Los Angeles...
Read Full Article
Credit Crunch Stalls Barclays’ Stellar Growth
Barclays reassured its nervous investors for the second time in a month today as it predicted that profits from the high street and at its Barclaycard credit card arm would more than offset a £...
Read Full Article

Insights: Clinical Trials May Not Represent Population


The randomized clinical trial, widely considered the most reliable biomedical research method, can have significant drawbacks, a new study suggests, because patients included may not be representative of the broader population.

Stuart Goldenberg

Related More Vital Signs Columns » Web LinkParticipation in Surgical Oncology Clinical Trials: Gender-, Race/Ethnicity-, and Age-based Disparities (The Annals of Surgical Oncology)

The scientists, writing in the December issue of The Annals of Surgical Oncology, reviewed 29 clinical trials of surgical procedures in prostate, colon, breast and lung cancer involving 13,991 patients. Although 62 percent of those cancers occur in people over 65, just 27 percent of the participants in the trials were that old. Although patients younger than 55 account for 16 percent of cancer cases, they made up 44 percent of the participants. More than 86 percent of the participants were white, and fewer than 8 percent African-American.

Thirty percent of the cases were breast cancers, but nearly 75 percent of the participants had that disease. Although prostate cancer accounted for 27 percent of the cancers, fewer than 2 percent of the patients were in prostate cancer studies.

In colon and lung cancer trials, women were less likely to be enrolled than men, and at all study sites, the rates of participation in trials was extremely low, from 0.04 to 1.7 percent.

Dr. John H. Stewart IV, the lead author and an assistant professor of surgery at Wake Forest University, said the disparities could call the results into question. “Our ability to generalize the findings of surgical trials,” he said, “is directly dependent on having equitable participation in trials by underrepresented groups.”

Tag Cloud

External Information

Additional Information

Gas Plant in L.I. Sound Is Rejected...
Scientists May Have Found Those Nabokov Baby Blues...
California: Whales on Course...
Discovery Crew Wraps Up Exam of Heat Shield...

Where Am I?

News Main Page - Business - Insights: Clinical Trials May Not Represent Population


 
i8news.com